Metabolomic analysis for combined hepatotoxicity of chlorpyrifos and cadmium in rats

• Published in: Toxicology (Amsterdam) Vol. 384; pp. 50 - 58
• Main Authors: Xu, Ming-Yuan, Wang, Pan, Sun, Ying-Jian, Wu, Yi-Jun
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01.06.2017
• Subjects: Animals; Cadmium; Cadmium - pharmacokinetics; Cadmium - toxicity; Catalase - metabolism; Chemical and Drug Induced Liver Injury - metabolism; Chemical and Drug Induced Liver Injury - pathology; Chlorpyrifos; Chlorpyrifos - pharmacokinetics; Chlorpyrifos - toxicity; Drug Interactions; Emergency; Environmental Pollutants - pharmacokinetics; Environmental Pollutants - toxicity; Gas Chromatography-Mass Spectrometry; Liver - drug effects; Liver - metabolism; Liver - pathology; Liver toxicity; Male; Malondialdehyde - metabolism; Metabolomics; Metabonomics; Metal; Pesticide; Pesticides - pharmacokinetics; Pesticides - toxicity; Protein Carbonylation - drug effects; Rats, Sprague-Dawley; Superoxide Dismutase - metabolism; Chlorpyrifos; Cadmium; Metal; Pesticide; Liver toxicity; Metabonomics
• ISSN: 0300-483X; 1879-3185
• DOI: 10.1016/j.tox.2017.04.008

Abstract Pesticides and heavy metals are widespread environmental pollutants. Although the acute toxicity of organophosphorus pesticide chlorpyrifos (CPF) and toxic heavy metal cadmium (Cd) is well characterized, the combined toxicity of CPF and Cd, especially the hepatotoxicity of the two chemicals with long-term exposure at a low dose, remained unclear. In this study, we investigated the toxicity in the liver of rats upon subchronic exposure to CPF and Cd at environmentally relevant doses. Rats were given three different doses (1/135 LD50 , 1/45 LD50 and 1/15 LD50 ) of CPF and Cd as well as their mixtures by oral gavage for 90 days. After treatment, the liver tissues were subjected to histopathological examination and biochemical analysis. Gas chromatography-mass spectrometry (GC-MS) was used to analyze the metabolomic changes in the rat liver upon CPF, Cd and their mixtures treatment. The results showed that CPF and Cd-induced oxidative damage and disrupted energy, amino acid, and fatty acid metabolism in the liver. Eleven biomarkers in liver were identified for CPF-, Cd-, and their mixture-treated rats. Three metabolites, i.e., butanedioic acid, myo -inositol, and urea, were identified as unique biomarkers for the mixture-treated rats. Moreover, we found that Cd could accelerate the metabolism of CPF in the liver when given together to the rats, which may lead to the potential antagonistic interaction between CPF and Cd. In conclusion, our results indicated that even at environmentally relevant doses, CPF and Cd could disrupt the liver metabolism. In addition, the accelerated metabolism of CPF by Cd may lead to their potential antagonistic interaction.